Nextech VII Oncology SCSp — Form D/A
Nextech VII Oncology SCSp of SENNINGERBERG, N4, a pooled investment fund, filed a Form D amendment with the SEC on 2023-04-13. $247.1M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2023-04-13
- Form: D/A
- Accession: 0001893825-23-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1, 3C.7
- Amount sold: $247.1M
- Investors: 95
- Date of first sale: 2021-11-24
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-421265
Issuer
- Name: Nextech VII Oncology SCSp
- CIK: 0001893825
- Entity type: Limited Partnership
- Jurisdiction: LUXEMBOURG
- Incorporated: 2021
- Address: 8, RUE LOU HEMMER, SENNINGERBERG, N4, L - 1748
- Phone: +352 24 61 60 6000
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| N/A Nextech VII GP S.a r.l. | Director | Senningerberg, N4 |
| Ian J Charoub | Executive Officer | Senningerberg, N4 |
| Costas J Constantinides | Executive Officer | Senningerberg, N4 |
| Jacob J Loven | Executive Officer | Zurich, V8 |
| Alfred J Scheidegger | Executive Officer | Zurich, V8 |
| Thilo J Schroeder | Executive Officer | Zurich, V8 |
| Rocco J Sgobbo | Executive Officer | Zurich, V8 |
| Ian Charoub | Executive Officer | Senningerberg, N4 |
| Dalia J Bleyer | Executive Officer | Senningerberg, N4 |
| Thilo Schroeder | Executive Officer | Grand Duchy of Luxembourg, N4 |
| Jacob Loven | Executive Officer | Zurich, V8 |
| Rocco Sgobbo | Executive Officer | Zurich, V8 |
| Alfred Scheidegger | Executive Officer | Zurich, V8 |
| Dalia Bleyer | Executive Officer | Senningerberg, N4 |
Other filings by this issuer (2)
More